Tandem Diabetes Care Inc TNDM Stock Forecast
AI-powered price prediction and analysis for Tandem Diabetes Care Inc · Alpha · vs marketSwitch to Total
See TNDM's Exact Price Target · Create a free account and follow this stock to unlock its full AI forecast — 3 stocks free.
Price Chart
Key Statistics
About Tandem Diabetes Care Inc
Tandem Diabetes Care Inc (TNDM) operates within the Industrial Applications and Services sector, specifically in the Surgical & Medical Instruments & Apparatus industry.
Latest News
Where TNDM sits on the market map
Surgical & Medical Instruments & Apparatus Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | AI Signal | Market Cap | P/E |
|---|---|---|---|
| TNDM Tandem Diabetes Care Inc | ▶ | $1.14B | – |
| SYK Stryker Corp | ▼ | $108.40B | 29.1x |
| MMM 3m Co | ▼ | $82.97B | 27.7x |
| BSX Boston Scientific Corp | ▼ | $62.77B | 17.1x |
| BDX Becton Dickinson & Co | ▼ | $51.04B | 54.2x |
| MDLN Medline Inc. | ▶ | $47.01B | – |
| RMD Resmed Inc | ▼ | $33.84B | 22.2x |
| DXCM Dexcom Inc | ▶ | $32.42B | 32.4x |
| WST West Pharmaceutical Services Inc | ▼ | $25.87B | 45.8x |
| SOLV Solventum Corp | ▼ | $14.52B | 10.1x |
| BAX Baxter International Inc | ▶ | $12.87B | – |
| PEN Penumbra Inc | ▼ | $12.64B | 78.7x |
| GMED Globus Medical Inc | ▼ | $10.24B | 19.1x |
| GKOS Glaukos Corp | ▲ | $9.91B | – |
| PODD Insulet Corp | ▼ | $9.70B | 25.8x |
| STVN Stevanato Group S.P.A. | ▲ | $5.83B | – |
| HAE Haemonetics Corp | ▼ | $5.55B | 57.7x |
| MMSI Merit Medical Systems Inc | ▼ | $5.36B | 36.8x |
| TFX Teleflex Inc | ▼ | $5.33B | – |
| MMED Minimed Group, Inc. | ▼ | $5.29B | – |
| HTFL Heartflow, Inc. | ▲ | $4.40B | – |
| ICUI Icu Medical Inc/De | ▼ | $4.10B | – |
| PLSE Pulse Biosciences, Inc. | ▶ | $3.74B | – |
| IRTC Irhythm Holdings, Inc. | ▼ | $3.52B | – |
| ATRC Atricure, Inc. | ▶ | $2.89B | – |
| UFPT Ufp Technologies Inc | ▶ | $2.29B | 31.7x |
| INSP Inspire Medical Systems, Inc. | ▶ | $2.07B | 15.3x |
| LMAT Lemaitre Vascular Inc | ▲ | $1.90B | 28.9x |
| NVCR Novocure Ltd | ▲ | $1.71B | – |
| ATEC Alphatec Holdings, Inc. | ▲ | $1.67B | – |
| KMTS Kestra Medical Technologies, Ltd. | ▲ | $1.60B | – |
| DRTS Alpha Tau Medical Ltd. | ▲ | $1.26B | – |
| IRMD Iradimed Corp | ▲ | $1.14B | 49.6x |
| BVS Bioventus Inc. | ▶ | $1.14B | 20.9x |
| PRCT Procept Biorobotics Corp | ▲ | $1.12B | – |
| IART Integra Lifesciences Holdings Corp | ▼ | $1.09B | – |
| AORT Artivion, Inc. | ▲ | $1.04B | – |
| SIBN Si-Bone, Inc. | ▲ | $901M | – |
| SGP Spyglass Pharma, Inc. | ▲ | $832M | – |
| BBNX Beta Bionics, Inc. | ▲ | $796M | – |
| MDXG Mimedx Group, Inc. | ▲ | $704M | – |
| KIDS Orthopediatrics Corp | ▶ | $576M | – |
| TCMD Tactile Systems Technology Inc | ▶ | $512M | 20.6x |
| SSII Ss Innovations International, Inc. | ▲ | $511M | – |
| SGHT Sight Sciences, Inc. | ▲ | $494M | – |
| BWAY Brainsway Ltd. | ▲ | $467M | – |
| CERS Cerus Corp | ▲ | $455M | – |
| ANGO Angiodynamics Inc | ▲ | $451M | – |
| NPCE Neuropace Inc | ▶ | $446M | – |
| RCEL Avita Medical, Inc. | ▲ | $413M | – |
| CARL Carlsmed, Inc. | ▲ | $395M | – |
| OFIX Orthofix Medical Inc. | ▼ | $378M | – |
| OBIO Orchestra Biomed Holdings, Inc. | ▲ | $355M | – |
| EMBC Embecta Corp. | ▲ | $351M | 4.0x |
| CLPT Clearpoint Neuro, Inc. | ▲ | $299M | – |
| MOBI Mobia Medical, Inc. | ▲ | $286M | – |
| ANIK Anika Therapeutics, Inc. | ▲ | $275M | – |
| OSUR Orasure Technologies Inc | ▲ | $270M | – |
| TMCI Treace Medical Concepts, Inc. | ▲ | $267M | – |
| PROF Profound Medical Corp. | ▲ | $265M | – |
FAQ
Is Tandem Diabetes Care Inc a good stock to buy?
Our AI analyzes Tandem Diabetes Care Inc daily. Check the signal above for the latest recommendation. Always do your own research before investing.
How accurate are Tandem Diabetes Care Inc predictions?
A per-ticker accuracy statistic for TNDM is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are forecasts updated?
Tandem Diabetes Care Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Ready to invest smarter? · Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Tandem Diabetes Care Inc? View full institutional-grade analysis on Intratio →
AI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.